Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

**Semantic type:** Intellectual Product

**Definition:** An international prognostic scoring system for myelodysplastic syndrome (MDS) that, unlike the revised international prognostic scoring system for myelodysplastic syndromes, combines genomic profiling with hematologic and cytogenetic parameters. It improves the risk stratification of patients with MDS and represents a valuable tool for clinical decision-making. (NEJM Evid 2022; 1(7))

**Synonyms:** - IPSS-M